Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Prescription drugs and its copycats contribute to health waste

Roy Benaroch, MD
Meds
June 14, 2010
Share
Tweet
Share

I’ve recently posted about the insane costs of health care, and about how defensive medicine is a big contributor. Prescription drugs are another huge cost, accounting for about 11% of the 2 trillion spent each year on health care in The United States. And it turns out that the marketplace for prescriptions is also rife with bizarre sources of waste and sneakery.

First, some good news: prescription medications are now available to treat a huge number of diseases. Got ulcers? No problem. Asthma? HIV? We can manage those. How about infertility, schizophrenia, seasonal allergies? Gotcha covered. There are a huge number of effective and reasonably safe medications out there, and a big part of our good health can be attributed to this growing armamentarium of really effective tools.

But those tools can sure be expensive, and you’re not always getting the value you might expect.

Take those seasonal allergies. Until about 10 years ago, the best medications were antihistamines like Benadryl. Effective, but they made people sleepy, and they had to be taken several times a day. Then came the newer gang of allergy meds, led I think first by Seldane (which has since been taken off the market for safety concerns).

Within a short time, Claritin came out, and millions of allergy sufferers could breathe better and sneeze less. What has happened since in the world of oral antihistamines? Well, nothing, really. Two other manufacturers came out with copycats -– Zyrtec and Allegra, which are really no better than Claritin, but earned their manufacturers piece of the pie.

Then, as Zyrtec approached the date of losing its patent, it’s maker came out with a true weasel-drug: Xyzal, which is in every practical way the exact same thing as Zyrtec. Works the same, same side effects, same everything– in fact the molecule itself is basically the same, it just all faces one direction rather than being a mix of right-handed and left-handed versions. Of course, they tried as hard as possible to switch as many patients over to Xyzal before generic Zyrtec became available.

Did this help anyone? Of course it did — the people who own shares in the company that makes Xyzal. A nearly-identical story occurred with the cleverly named “Nexium” (get it? next?), which has no possible advantage over the drug it replaced, Prilosec. Except of course it’s still protected by patent.

Copycats are drugs made by one manufacturer to cleave off some market share; though they don’t directly help patients any more than the originals, at least in theory they help keep prices low through competition. Drugs like Nexium and Xyzal aren’t copycats– they’re just patent-extenders, and by no stretch of the imagination are they helping health care in any way. They just drive up costs.

Another example: “Flonase” can be squirted up your nose to treat and prevent allergy symptoms. It’s a terrific medication — it works, and it’s safe for almost everyone. Just as the patent expired, the manufacterer came out with a nearly-identical medication, but put it in a bottle where the squirt-button is on the side, rather than the top. Got it? You hold the bottle differently to squirt it up your nose. They somehow got a patent extension for “Veramyst,” and for reasons I can’t possibly imagine physicians are actually writing prescriptions for it.

Wise doctor: “Ms. Johnson, this product is far more expensive because there’s no generic, but I’m sure you realize how crucial it is that you can squirt it with your hand sideways rather than upright.”

Besides coming up with copycats and patent-extending tweaks, drug companies have other tricks to fend off patents. In some cases, they just pay off generic manufacturers to delay their selling copies of the drug.

Doctors who prescribe these things without regards to costs share the blame. We’re too easily influenced by the ubiquitous drug reps, who bring gifts and goodies and wear low-cut blouses. Sometimes, doctors become even more enmeshed with the drug companies — I’ve been offered thousands of dollars to give talks in support of one antibiotic, as well as travel perks for myself and my family.

The drug companies can’t directly influence purchasing without going through a doctor, right?

ADVERTISEMENT

Wrong. Direct-to-consumer ads are all over the place, and have helped create huge markets for drugs for erectile dysfunction (a term invented by drug marketers) and restless legs syndrome. Not only do direct ads push specific drugs — “Ask your doctor if Vyvtera is right for you” — but indirect ads create a market by publicizing the existence of a disease. Had you ever heard of restless legs syndrome before there was a medication that could be sold to treat it?

(I don’t mean to pick on RLS. It’s a real disease, and it’s really debilitating. But drugs have been available for years to treat it. Only when one name-brand medication got an FDA-approved indication for RLS did anything about this condition appear in the press. I wonder how an administrative decision to approve a medication led to such widespread media attention. Spooky.)

And don’t even think about the bizarre ways that medicine prices are determined in the USA, or how the same medications, manufactured by the same companies, have vastly different prices in different countries. You want to make sense out of that?

Though they account for “only” 11% of health care expenditures, prescription medications are a good example of what’s both good and bad about American medicine. Many treatments are available, for many, many conditions — but the prices of the treatments are utterly nonsensical, and the prices have very little to do with how well the treatments are going to work, or how essential the medication really is. And the people who should be in control of deciding which medicine is “best” often don’t seem to care about which medicine is the most cost-effective.

Recent health care legislation has rearranged the deck chairs, but the ship is still going down under the weight of huge costs that no one is willing to face.

Roy Benaroch is a pediatrician who blogs at The Pediatric Insider. He is also the author of Solving Health and Behavioral Problems from Birth through Preschool: A Parent’s Guide and A Guide to Getting the Best Health Care for Your Child.

Prev

Statins do not decrease the risk of many cancers

June 14, 2010 Kevin 0
…
Next

Medical loss ratios is not all about health insurance profits

June 14, 2010 Kevin 2
…

Tagged as: Medications, Public Health & Policy

Post navigation

< Previous Post
Statins do not decrease the risk of many cancers
Next Post >
Medical loss ratios is not all about health insurance profits

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Roy Benaroch, MD

  • Goodbye, Benadryl: It is time for you to retire

    Roy Benaroch, MD
  • Telemedicine overprescribes antibiotics: Are you really receiving the best care over the phone?

    Roy Benaroch, MD
  • No, phones don’t cause horns to grow on skulls

    Roy Benaroch, MD

More in Meds

  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Reimagining Type 2 diabetes care with nutrition for remission [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Reimagining Type 2 diabetes care with nutrition for remission [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI is revolutionizing health care through real-world data

      Sujay Jadhav, MBA | Tech
    • Ambient AI: When health monitoring leaves the screen behind

      Harvey Castro, MD, MBA | Tech
    • How kindness in disguise is holding women back in academic medicine

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why physician voices matter in the fight against anti-LGBTQ+ laws

      BJ Ferguson | Policy
    • From burnout to balance: a lesson in self-care for future doctors

      Seetha Aribindi | Education

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 9 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Addressing the physician shortage: How AI can help, not replace

      Amelia Mercado | Tech
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Reimagining Type 2 diabetes care with nutrition for remission [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Residency as rehearsal: the new pediatric hospitalist fellowship requirement scam

      Anonymous | Physician
    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
  • Recent Posts

    • Reimagining Type 2 diabetes care with nutrition for remission [PODCAST]

      The Podcast by KevinMD | Podcast
    • How AI is revolutionizing health care through real-world data

      Sujay Jadhav, MBA | Tech
    • Ambient AI: When health monitoring leaves the screen behind

      Harvey Castro, MD, MBA | Tech
    • How kindness in disguise is holding women back in academic medicine

      Sylk Sotto, EdD, MPS, MBA | Conditions
    • Why physician voices matter in the fight against anti-LGBTQ+ laws

      BJ Ferguson | Policy
    • From burnout to balance: a lesson in self-care for future doctors

      Seetha Aribindi | Education

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Prescription drugs and its copycats contribute to health waste
9 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...